Metabolic abnormalities in renal transplant recipients. Risk factors and predictors of chronic graft dysfunction?
In summary, abnormalities in lipid and carbohydrate metabolism, including features of the metabolic risk factor syndrome, are frequently present in patients both before and after renal transplantation. Risk factors of atherosclerosis may not only contribute to increased cardiovascular morbidity and mortality in this patient population, but can also be assumed to contribute to the development and progression of CVR and chronic graft dysfunction. For preventing both early graft losses and the development of graft damage leading to late graft dysfunction and graft loss, it appears to be essential to identify patients at risk early, prior to transplantation. Intervention aiming to reduce overweight, diet and exercise may be of benefit. The role of omega-3 unsaturated fatty acid supplementation remains controversial. Pharmacological intervention by antioxidants or agents to reduce lipids and/or decrease PAI-1 synthesis may prove to be beneficial. Early identification of patients at risk and intervention in due time may improve the results of renal transplantation.
Dimény
E
E
Fellström
B
B
D005342:Fibrinolysis; D006084:Graft Rejection / Q000209:etiology* / Q000378:metabolism*; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000502:physiology; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D012307:Risk Factors; D013577:Syndrome
D017395:Plasminogen Activator Inhibitor 1